Association of Thyroid Function With Lipid Profile in Patients With Metabolic Syndrome: A Prospective Cross-Sectional Study in the Indian Population

被引:5
作者
Abha, Priti [1 ]
Keshari, J. R. [2 ]
Sinha, Seema R. [1 ]
Nishant, Kumar [3 ]
Kumari, Rekha [1 ]
Prakash, Prem [4 ]
机构
[1] Indira Gandhi Inst Med Sci, Biochem, Patna, India
[2] Indira Gandhi Inst Med Sci, Biochem, Patna, India
[3] Jawaharlal Nehru Med Coll & Hosp, Pediat, Bhagalpur, India
[4] Indira Gandhi Inst Med Sci, Gen Surg, Patna, India
关键词
dyslipidemia; insulin resistance; waist circumference; subclinical hypothyroidism; hypothyroidism; metabolic syndrome; COMPONENTS; OBESITY; DYSFUNCTION;
D O I
10.7759/cureus.44745
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionMetabolic syndrome is a group of aberrant metabolic indicators including hypertension, dyslipidemia, impaired fasting blood glucose, and obesity. It has been reported that thyroid hormones have a strong influence on the cardiovascular system, and hypothyroidism has been linked to metabolic syndrome components. The objective of the study was to find out the association of thyroid function with lipid profile in patients with metabolic syndrome.MethodsA prospective cross-sectional study was conducted in an apparently healthy adult population visiting the outpatient Department of Indira Gandhi Institute of Medical Sciences (IGIMS), Patna, Bihar, India. Metabolic syndrome was diagnosed according to the International Diabetes Federation (IDF) criteria. Fasting blood glucose, triglyceride, and HDL levels were tested using the enzymatic photometric method. Thyroid -stimulating hormone (TSH), free T4, free T3, and insulin assays were performed using chemiluminescence immunoassay (CLIA).ResultsOut of 197 subjects recruited, 86 (51 males and 35 females) were diagnosed with metabolic syndrome according to the IDF criteria, and the rest 111 without metabolic syndrome were considered to be the controls. The mean age of subjects with and without metabolic syndrome was 45.8 +/- 8.5 and 46.4 +/- 9.6 years, respectively. The prevalence of thyroid dysfunction in the present study was 22%. In subjects with metabolic syndrome, most of the clinical and hormonal parameters (waist circumference, waist-height ratio, fasting blood sugar, fasting insulin, triglycerides, T3, and TSH) were significantly higher (p<0.001) as compared to those without metabolic syndrome. In case of lipid profile, the triglycerides in those with metabolic syndrome (262.8 +/- 112.3 mg/dL) were significantly higher (p<0.001) than those without metabolic syndrome (137.9 +/- 19.01 mg/dL), while the serum levels of HDL were significantly higher (p<0.001) in group without metabolic syndrome (50.5 +/- 3.9 mg/dL) as compared to those with metabolic syndrome (43.4 +/- 5.2 mg/dL). Also, the TSH levels were significantly higher (p<0.001) in subjects with metabolic syndrome (5.3 +/- 3.4 mu l/mL) as compared to those without metabolic syndrome (2.6 +/- 1.4 mu l/mL). Among all the components of metabolic syndrome, waist circumference and HDL showed a significant strong positive correlation (r=0.51) with TSH, and systolic blood pressure (r=0.39), diastolic blood pressure (r=0.39), and fasting blood sugar levels (r=0.44) showed significantly moderate positive correlation with TSH levels. T4 (OR=8.82; 95% CI: 1.56-49.8) and TSH (OR=1.61; 95% CI: 1.19-2.18) levels were observed to have significantly higher odds as risk factors for metabolic syndrome.ConclusionThere is a significant association of thyroid function with lipid profile in metabolic syndrome. It was observed that along with metabolic alterations, cardiovascular symptoms of hypothyroidism and subclinical hypothyroidism are possible. Therefore, while evaluating people with metabolic syndrome, it may be appropriate to look into how well their thyroid glands are functioning.
引用
收藏
页数:9
相关论文
共 30 条
[1]  
Agarwal G, 2011, J CLIN DIAGN RES, V5, P213
[2]   Thyroid Function Assessment in Saudi Males with Metabolic Syndrome [J].
Aldhafiri, Fahad Khalid ;
Abdelgawad, Fathy Elsayed ;
Bakri, Gihan Mohamed Mohamed ;
Saber, Tamer .
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2021, 13 (04) :352-359
[3]  
Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI [10.2337/dc14-S081, 10.2337/dc11-S062, 10.2337/dc13-S067, 10.2337/dc10-S011, 10.2337/dc13-S011, 10.2337/dc11-S011, 10.2337/dc12-s064, 10.2337/dc12-s011, 10.2337/dc10-S062]
[4]  
Anil Sharma Anil Sharma, 2017, JK Science, V19, P115
[5]  
Bastemir M, 2007, SWISS MED WKLY, V137, P431
[6]  
Bhalwar Rajvir, 2020, Med J Armed Forces India, V76, P8, DOI 10.1016/j.mjafi.2019.12.001
[7]   Initial thyroid status and cardiovascular risk factors: The EPIC-Norfolk prospective population study [J].
Boekholdt, S. Matthijs ;
Titan, Silvia M. ;
Wiersinga, Wilmar M. ;
Chatterjee, Krishna ;
Basart, Dick C. G. ;
Luben, Robert ;
Wareham, Nicholas J. ;
Khaw, Kay-Tee .
CLINICAL ENDOCRINOLOGY, 2010, 72 (03) :404-410
[8]   Thyroid Dysfunction in Metabolic Syndrome Patients in a Tertiary Care Hospital [J].
Chakradhar, M. ;
Chakravarthy, D. J. K. ;
Dorapudi, Bhaskar S. C. H. ;
Deedi, Kiran M. ;
Prasad, Bhavani N. .
JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2020, 9 (30) :2103-2108
[9]   Thyroid Dysfunction in Patients with Metabolic Syndrome: A Cross-Sectional, Epidemiological, Pan-India Study [J].
Deshmukh, Vaishali ;
Farishta, Faraz ;
Bhole, Milind .
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2018, 2018
[10]   The metabolic syndrome [J].
Eckel, RH ;
Grundy, SM ;
Zimmet, PZ .
LANCET, 2005, 365 (9468) :1415-1428